Roy Winston - Nov 4, 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Medical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Nov 4, 2021
Transactions value $
$481,500
Form type
4
Date filed
11/8/2021, 03:22 PM
Previous filing
Aug 5, 2021
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $482K +10K +27.43% $48.15 46.5K Nov 4, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -10K -40% $0.00 15K Nov 4, 2021 Common Stock 10K $48.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.